CANNAPHARMARX, INC.: 10-Q filed 2014-05-19

Name: CANNAPHARMARX, INC.: 10-Q filed 2014-05-19
Creator: CANNAPHARMARX, INC.

What CANNAPHARMARX, INC. reported in its quarterly report filed 2014-05-19 (fiscal Q1 2014): 18 published measures, 52 facts as tagged in accession 0001072588-14-000048.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-05-19
Fiscal period: fiscal Q1 2014
Accession: 0001072588-14-000048 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANNAPHARMARX, INC. filings.

Reported measures

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-03-31	317,672	USD
At 2013-12-31	292,034	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2014-03-31	-317,672	USD
At 2013-12-31	-292,034	USD
At 2012-12-31	-197,628	USD
At 2011-12-31	-99,561	USD
At 2010-12-31	100	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-03-31	25	USD
At 2012-12-31	25	USD
At 2010-12-31	100	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-25,638	USD	90
2011-01-01 to 2014-03-31	-317,772	USD	1186
2013-01-01 to 2013-12-31	-94,406	USD	365
2013-01-01 to 2013-03-31	-22,893	USD	90
2012-01-01 to 2012-12-31	-98,067	USD	366
2011-01-01 to 2011-12-31	-99,661	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-6,047	USD	90
2011-01-01 to 2014-03-31	-40,081	USD	1186
2013-01-01 to 2013-03-31	-5,400	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	6,047	USD	90
2011-01-01 to 2014-03-31	39,981	USD	1186
2013-01-01 to 2013-03-31	5,400	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-03-31	-17,192,553	USD
At 2013-12-31	-17,166,915	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-21,108	USD	90
2011-01-01 to 2014-03-31	-288,089	USD	1186
2013-01-01 to 2013-03-31	-19,976	USD	90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-03-31	317,672	USD
At 2013-12-31	292,034	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-03-31	52,718	USD
At 2013-12-31	52,206	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	21,108	USD	90
2011-01-01 to 2014-03-31	288,089	USD	1186
2013-01-01 to 2013-03-31	19,976	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-03-31	2,384,407	shares
At 2013-12-31	2,384,407	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-03-31	16,874,642	USD
At 2013-12-31	16,874,642	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-03-31	29,973	USD
At 2013-12-31	25,894	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-25,638	USD	90
2011-01-01 to 2014-03-31	-317,772	USD	1186
2013-01-01 to 2013-03-31	-22,893	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	21,108	USD	90
2011-01-01 to 2014-03-31	288,089	USD	1186
2013-01-01 to 2013-03-31	19,976	USD	90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-4,530	USD	90
2011-01-01 to 2014-03-31	-29,683	USD	1186
2013-01-01 to 2013-03-31	-2,917	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	510	USD	90
2011-01-01 to 2014-03-31	52,716	USD	1186
2013-01-01 to 2013-03-31	-424	USD	90

Inspect the source

Entity: CANNAPHARMARX, INC. / CIK 0001081938
Captured: 2026-09-20T05:20:43.396Z
SEC response SHA-256: 5d42938250dbbcfa19092cae39e1ddd591085d080af4dafac930684703fc6a67

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001081938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))